secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2023-07-26T23:59:59+00:00
Accession:  0001493152-23-025606
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen sells FastPack diagnostics business for $5.1M; deconsolidates Nanosynex
--------------------------------------------------------------------------------

- Base sale price $5.8M; net cash received $4.7M at closing plus $450K escrow for indemnification.
- FastPack diagnostics business sold to Chembio Diagnostics (subsidiary of Biosynex) in all-cash deal closed July 20, 2023.
- Qualigen's ownership in Nanosynex reduced from 52.8% to 49.97% via surrender of preferred B shares; $2.88M notes cancelled; deconsolidation.
- Company will advance $1.23M total to Nanosynex in two tranches by March 2024 against promissory notes.
- Pro forma shows cash and cash equivalents increase to $7.6M from $4.4M historical; retained equity method investment of $2.94M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315223025606/0001493152-23-025606-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315223025606/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-025606

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer